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Introduction {#sec005}
============

Dystonia is a common but heterogeneous movement disorder. It is estimated to be the third most frequent movement disorder worldwide \[[@pone.0169934.ref001]\]. However, for most dystonia cases the nature and cause remains largely unknown \[[@pone.0169934.ref002]\]. Increased cortex plasticity through the entire sensorimotor system \[[@pone.0169934.ref003], [@pone.0169934.ref004]\] and functional modifications of the olivo-cerebellar pathway \[[@pone.0169934.ref005]\] were recognized as endophenotypes of dystonia. Moreover, reduced integrity of cerebello-thalamo-cortical tracts has been observed in symptomatic and asymptomatic carriers of dystonia-linked genes mutations \[[@pone.0169934.ref006]\].

Recently, a new general definition and a new classification of dystonia have been proposed \[[@pone.0169934.ref007]\]. Classification is now based on two distinct axes: the etiology and the clinical features, which include age at onset, body distribution, temporal pattern and coexistence of other movement disorders. The widely used term "primary" has been replaced with the term "isolated", where dystonia is the only motor feature, not counting tremor \[[@pone.0169934.ref007]\].

TOR1A gene (also known as DYT1) covers an 11k bp region in chr9 and it is consisted of 5 exons. TOR1A protein, called TorsinA belongs to the family of the AAA+ ATPases that can be found in the endoplasmic reticulum and nuclear envelope of most cells \[[@pone.0169934.ref008]\] including cells of the central nervous system \[[@pone.0169934.ref001]\] and are associated with a variety of cellular activities \[[@pone.0169934.ref009]\]. The function of TorsinA and how TOR1A gene mutations lead to dystonia is poorly understood. However, it seems that TorsinA is implicated in several molecular and cellular procedures, such as the interactions between cytoskeleton and membrane, important functions of the endoplasmic reticulum (reaction to stress, secretory pathway, protein degradation, neurites' expansion) and of the nuclear envelope (membrane formation and cell migration) \[[@pone.0169934.ref001], [@pone.0169934.ref008]\].

Relatively few genetic loci have been identified as potential causing factors of hereditary forms of isolated and combined dystonia, with a wide variation in the mode of inheritance, clinical features, body distribution and age of onset. The DYT1 (TOR1A) form of hereditary dystonia is mainly a generalized (and rarely focal) dystonia, which is inherited by an autosomal dominant mode \[[@pone.0169934.ref010]\]. Regarding sporadic dystonia, a number of genes have been linked to dystonia phenotypes including but not limited to TOR1A, b-cystathionine synthase (CBS), GTP cyclohydrolase1 (GCH1), dopamine D5 receptor (DRB5) and brain-derive neurotrophic factor (BDNF) genes \[[@pone.0169934.ref011]--[@pone.0169934.ref021]\]. Moreover, apolipoprotein E (APOE) gene has been reported to modulate the age at onset of primary dystonia \[[@pone.0169934.ref022]\]. However, TOR1A gene remains the most extensively studied and related to a variety of phenotypes but with conflicting results \[[@pone.0169934.ref023]\].

Two meta-analyses evaluated, so far, the effects of TOR1A gene variants on primary dystonia \[[@pone.0169934.ref014], [@pone.0169934.ref024]\], whereas there is also one pooled analysis in adult-onset primary focal dystonia \[[@pone.0169934.ref023]\]. In the first meta-analysis no significant association was found \[[@pone.0169934.ref014]\], whereas in the second meta-analysis a borderline significant association was reported for the rs1801968 in the subgroup of patients with primary dystonia that also had a positive family history \[[@pone.0169934.ref024]\]. Similarly, the pooled analysis that examined the effect of rs2296793 and rs1801968 variants on adult-onset primary focal dystonia also did not reveal any significant difference between cases and controls \[[@pone.0169934.ref023]\].

The previous two meta-analyses \[[@pone.0169934.ref014], [@pone.0169934.ref024]\] used as a clinical outcome endpoint all forms of primary dystonia together without focusing on each dystonia sub-phenotype such as cervical dystonia, blepharospasm or writer's cramp. Moreover, the pooled analysis of adult-onset primary focal dystonia cases \[[@pone.0169934.ref023]\] studied only two (rs2296793, rs1801968) of TOR1A gene variants and part of the available studies was used. In the present meta-analysis we aimed to study the effect of all available TOR1A gene SNPs on the risk of dystonia and its sub-phenotypes. Our meta-analysis has included five additional studies that have been published recently and were not included in the previous meta-analyses.

Methods {#sec006}
=======

Data extraction {#sec007}
---------------

Eligible case-control candidate gene association studies (GAS) were selected by searching Pubmed database. The combination of search strings that was used included the following terms: "dystonia" and "tor1a" and "polymorphism". The complete search algorithm is available in the **[S1 Appendix](#pone.0169934.s001){ref-type="supplementary-material"}**. We imposed no language or other restrictions. Last literature search was performed on September 9th, 2016. The reference lists of all retrieved articles were additionally examined to identify studies that may have been missed by the initial database search. The inclusion criteria were a) case-control studies, in which cases were clinically diagnosed of having dystonia and controls were neurologically healthy, b) studies reporting single nucleotide polymorphisms in the TOR1A gene and c) studies that mentioned in the text the genotype frequencies from patients and controls. Studies with incomplete data or without genotype frequencies were excluded from meta-analysis. The initial phenotypic classifications of participants in each study were maintained.

The following information was extracted from each study: author, year of publication, ethnicity of the studied population, numbers of cases and controls, age at disease onset, mean age and gender distribution, genotype frequencies, tested polymorphisms, family history of the participants, method of diagnosis, screening or not of TOR1A ΔGAG mutation, deviation or not from the Hardy-Weinberg Equilibrium (HWE), and tested dystonia phenotypes.

All individual studies were reviewed and the risk of possible bias was assessed. The flowchart presenting the selection procedure of eligible studies is presented in **[Fig 1](#pone.0169934.g001){ref-type="fig"}**.

![Flow chart presenting the selection of eligible studies.](pone.0169934.g001){#pone.0169934.g001}

Statistical analysis {#sec008}
--------------------

Dystonia cases were stratified according to the five following phenotypic qualitative traits: a) an overall dystonia group, b) an overall focal dystonia group (containing cervical dystonia, blepharospam, writer's cramp and other focal dystonias) and the three following focal dystonias' subgroups c) the cervical dystonia group, d) the blepharospasm group and f) the writer's cramp group. In each of the previous phenotypic traits, available TOR1A polymorphisms were tested in the meta-analysis. The association between the TOR1A SNPs and the above mentioned dystonia traits was estimated by calculating the pooled odds ratio (OR) and 95% confidence interval (CI) assuming the dominant \[(mt/mt+wt/mt) vs (wt/wt)\] and the recessive \[(mt/mt) vs (wt/mt+wt/wt)\] genetic modes of inheritance. The significance of the OR was determined by the Z test (p\<0.05 was considered statistically significant). Additionally, the generalized odds ratio (OR~G~) and the corresponding 95%C.I. were applied in order to quantify the association between genotype distribution and disease. OR~G~ is an inheritance model free approach that estimates the mutational load in cases compared to the controls \[[@pone.0169934.ref025], [@pone.0169934.ref026]\]. ORs and OR~G~s with the corresponding 95 C.I. were also calculated in every individual eligible GAS.

The statistical heterogeneity of the studies was calculated with the Cochran's Q and I^2^ index. The random-effects model (the DerSimonian and Laird method \[[@pone.0169934.ref027]\]) was applied if there was an indication of substantial heterogeneity (P~Q~ \<0.10 and/or I^2^\>75%). Otherwise the fixed-effects model (the Mantel-Haenszel method \[[@pone.0169934.ref028]\]) was used.

Test for possible publication bias was graphically assessed using the funnel plot. Furthermore, it was evaluated by the linear regression asymmetry test by Egger \[[@pone.0169934.ref029]\], when it was applicable, with p\<0.10 considered to be representative of statistically significant publication bias.

All statistical analyses were performed in Review Manager (RevMan) Version 5.2 software \[The Nordic Cochrane Centre, The Cochrane Collaboration, Copenhagen, Denmark (<http://tech.cochrane.org/revman>)\]. The OR~G~ was calculated with ORGGASMA ([www.biomath.uth.gr](http://www.biomath.uth.gr/)) software. The PRISMA guidelines for reporting reviews and meta-analyses (**[S2 Appendix](#pone.0169934.s002){ref-type="supplementary-material"}**) were applied in this meta-analysis.

Results {#sec009}
=======

Study selection and study characteristics {#sec010}
-----------------------------------------

Pubmed database search yielded 34 studies published between September 1997 and March 2016. After title and abstract screening by 2 independent reviewers (VS and ED), 16 potentially eligible studies for the meta-analysis were retained. One additional study was extracted from the references of the identified studies and was included in the meta-analysis \[[@pone.0169934.ref030]\]. However, one study was excluded from further analysis, as it did not report genotype frequencies \[[@pone.0169934.ref031]\] and therefore 16 studies were finally included in the quantitative meta-analysis \[[@pone.0169934.ref014], [@pone.0169934.ref016], [@pone.0169934.ref020], [@pone.0169934.ref023], [@pone.0169934.ref024], [@pone.0169934.ref030], [@pone.0169934.ref032]--[@pone.0169934.ref041]\], involving in total 3103 dystonia cases and 3628 healthy controls. In total 9 TOR1A SNPs have been investigated so far (rs1801968 and rs2296793 in ten studies, rs1182 and rs3842225 in nine, rs13283584, rs11787741 and rs13297609 in two and rs2287367 and rs1043186 in one study). One study revealed an association of a haplotype (constructed from rs2296793, rs1182 and rs3842225) with sporadic dystonia \[[@pone.0169934.ref036]\] while another one revealed a strong association of rs13283584 with idiopathic dystonia \[[@pone.0169934.ref038]\]. Association of rs1801968 with primary dystonia was reported in three studies \[[@pone.0169934.ref033], [@pone.0169934.ref039], [@pone.0169934.ref041]\] while another one revealed significant association only in cases with positive family history \[[@pone.0169934.ref032]\]. Association or a tendency for association of rs1182 was reported in three studies \[[@pone.0169934.ref037], [@pone.0169934.ref038], [@pone.0169934.ref040]\].

The majority of the studies were conducted in Chinese (n = 5) \[[@pone.0169934.ref020], [@pone.0169934.ref023], [@pone.0169934.ref034], [@pone.0169934.ref035], [@pone.0169934.ref041]\] and German (n = 4) \[[@pone.0169934.ref016], [@pone.0169934.ref030], [@pone.0169934.ref032], [@pone.0169934.ref038]\] populations. 10 studies reported inclusion of patients with positive family history of dystonia \[[@pone.0169934.ref020], [@pone.0169934.ref024], [@pone.0169934.ref032]--[@pone.0169934.ref035], [@pone.0169934.ref038]--[@pone.0169934.ref041]\] dystonia and in one study \[[@pone.0169934.ref041]\] was reported inclusion of participants positive for the ΔGAG TOR1A mutation. The characteristics of the included studies are summarized in **[S1 Table](#pone.0169934.s004){ref-type="supplementary-material"}**. Detailed information of the tested TOR1A SNPs is presented in **[S2 Table](#pone.0169934.s005){ref-type="supplementary-material"}**. There was no reported deviation from HWE in controls at any protocol. At another one, where two different populations were tested, we analyzed them separately in the meta-analysis \[[@pone.0169934.ref037]\].

Tests of heterogeneity {#sec011}
----------------------

Significant heterogeneity was revealed in the total dystonia group for a number of SNPs: rs1801968 (I^2^ = 53%, P~Q~ = 0.03 for dominant mode and I^2^ = 54.63%, P~Q~ = 0.002 for model free), rs2296793 (I^2^ = 42%, P~Q~\<0.07 for recessive mode), rs1182 (I^2^ = 72%, P~Q~ = 0.00002 for dominant mode, I^2^ = 42%, P~Q~ = 0.08 for recessive mode and I^2^ = 81.98%, P~Q~\<0.0001 for model free), rs13283584 (I^2^ = 79% and P~Q~ = 0.03 for both dominant and recessive modes and I^2^ = 65.72%, P~Q~ = 0.09 for model free), rs11787741 (I^2^ = 79%, P~Q~ = 0.03 for recessive mode). No significant heterogeneity was observed in the entire focal dystonia group and in the focal dystonia subgroups (cervical dystonia, blepharospasm and writer's cramp). In case of considerable heterogeneity, the random-effects models were applied as previously described.

Publication bias {#sec012}
----------------

Funnel plots, which are presented in **[Fig 2](#pone.0169934.g002){ref-type="fig"}**for the overall dystonia group and in **[Fig 3](#pone.0169934.g003){ref-type="fig"}**for the focal dystonia group and focal dystonia subgroups, did not reveal any significant asymmetry for any tested SNP in the dominant or recessive modes. Results from Egger's test (**[S3 Appendix](#pone.0169934.s003){ref-type="supplementary-material"}**) revealed no publication bias (P\>0.10) in the dominant or recessive modes.

![Funnel plot assessing evidence of publication bias in overall studies for TOR1A SNPs included in meta-analysis for overall dystonia group, in dominant and recessive modes of inheritance.\
SE, standard error; OR, odds ratio.](pone.0169934.g002){#pone.0169934.g002}

![Funnel plot assessing evidence of publication bias in overall studies for TOR1A SNPs included in meta-analysis for entire focal dystonia group and focal dystonia subgroups (cervical dystonia, blepharospasm and writer's cramp), in dominant and recessive modes of inheritance.\
SE, standard error; OR, odds ratio.](pone.0169934.g003){#pone.0169934.g003}

Overall dystonia group analysis and subgroup analyses {#sec013}
-----------------------------------------------------

The main results of meta-analysis for all available SNPs in the overall dystonia group are presented as forest plots in **[Fig 4](#pone.0169934.g004){ref-type="fig"}**. A tendency towards association was found for rs1182 in the recessive inheritance mode \[Odds Ratio, OR (95% confidence interval, C.I.): 1.60 (0.98--2.62)\]. The main meta-analysis results for the entire focal dystonia group and the focal dystonia subgroups (cervical dystonia, blepharospasm and writer's cramp) are shown in **[Fig 5](#pone.0169934.g005){ref-type="fig"}**. The respectively results after the meta-analysis with the model-fee approach and the genotypes frequencies, are showed at **[Table 1](#pone.0169934.t001){ref-type="table"}**for the overall dystonia group and at **[Table 2](#pone.0169934.t002){ref-type="table"}**for the focal dystonia group and focal dystonias' subtypes. Overall, rs1182 was found to be associated with focal dystonia in recessive mode \[OR (95%C.I.): 1.83 (1.14--2.93), P~z~ = 0.01\]. Moreover, rs1801968 has found to be associated with writer's cramp in both recessive and dominant modes \[OR (95%C.I.): 5.99 (2.08--17.21), P~z~ = 0.00009\] and \[OR (95%C.I.): 2.48 (1.36--4.51), P~z~ = 0.003)\] respectively and in model free-approach \[ORG (95%C.I.): 2.58 (1.45--4.58)\].

![Odds ratios of dystonia associated with TOR1A polymorphisms in overall studies included in meta-analysis, in dominant (left) and recessive (right) modes of inheritance.](pone.0169934.g004){#pone.0169934.g004}

![Odds ratios of entire focal dystonia group and focal dystonia subgroups (cervical dystonia, blepharospasm and writer's cramp) associated with TOR1A polymorphisms in overall studies included in meta-analysis, in dominant (left) and recessive (right) modes of inheritance.](pone.0169934.g005){#pone.0169934.g005}
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###### Quantitate measures of genetic risk (individual study estimates and pooled effects), stratified by polymorphism of interest, for overall dystonia group, with the generalized odds ratio (OR~G~).

![](pone.0169934.t001){#pone.0169934.t001g}

  SNP              Author (Year)             Controls   Cases   Model-free   Model                                  
  ---------------- ------------------------- ---------- ------- ------------ ------- ----- ---- ------------------- --------
                   Siblling (2003)           79         16      5            78      20    2    1.02 (0.53--1.96)   
                   Naiya (2006)              52         11      0            103     6     1    0.32 (0.12--0.85)   
                   Kamm (2006)               393        122     6            183     54    6    1.02 (0.72--1.45)   
                   Bruggemann (2009)         184        53      4            242     90    9    1.32 (0.91 1.91)    
                   Newman(2012)              150        44      3            153     50    2    1.07 (0.69--1.68)   
                   Groen (2013)              267        84      9            262     91    11   1.12 (0.81--1.54)   
                   Chen (2012)               86         9       5            168     29    13   1.49 (0.79--2.82)   
                   Cheng (2013)              152        42      6            101     20    0    0.63 (0.36--1.11)   
                   Caputo (2013)             161        39      0            24      16    0    2.80 (1.37--5.70)   
                   Wang (2016)               109        20      2            102     14    1    0.73 (0.36--1.47)   
                   Pooled data               1633       440     40           1146    390   45   1.06 (0.83--1.35)   Random
                   Heterogenity I^2^                                                            54.63%              
                   P~Q~                                                                         0.002               
  **rs2296793**                                                                                                     
                   Sibbing (2003)            66         29      5            56      37    7    1.49 (0.87--2.55)   
                   Clarimon (2005)           64         33      3            47      31    8    1.55 (0.89--2.69)   
                   Hague (2006)              159        87      9            138     77    8    1.02 (0.71--1.45)   
                   Kamm (2006)               312        185     24           163     76    4    0.72(0.53--0.97)    
                   Clarimon (2007) U.S.      137        96      14           39      33    1    1.00 (0.61--1.63)   
                   Clarimon (2007) Italian   59         51      19           52      46    9    0.82 (0.52--1.29)   
                   Newman(2012)              124        72      7            122     69    16   1.16(0.79--1.68)    
                   Groen (2013)              211        131     15           213     129   19   1.02(0.77--1.35)    
                   Cheng (2013)              129        68      3            68      52    1    1.39 (0.88--2.18)   
                   Zhou (2015)               194        90      5            132     61    8    1.10 (0.76--1.59)   
                   Wang (2016)               80         46      5            82      30    5    0.69 (0.42--1.16)   
                   Pooled data               1535       888     109          1112    641   86   1.00 (0.89--1.14)   Fixed
                   Heterogenity I^2^                                                            30.89%              
                   P~Q~                                                                         0.15                
  **rs1182**                                                                                                        
                   Clarimon (2005)           69         29      1            49      29    8    1.86(1.04--3.31)    
                   Hague (2006)              169        80      5            144     73    6    1.09 (0.75--1.59)   
                   Kamm (2006)               218        212     21           183     55    4    0.31 (0.22--0.44)   
                   Clarimon (2007) U.S.      144        89      9            43      28    0    0.93 (0.55--1.56)   
                   Clarimon (2007) Italian   79         49      3            73      40    12   1.19 (0.75--1.91)   
                   Newman(2012)              117        66      6            129     62    14   1.02 (0.72--1.45)   
                   Groen (2013)              225        122     11           225     120   16   1.04 0.78--1.39)    
                   Chen (2012)               205        86      3            202     84    5    1.02 (0.72--1.45)   
                   Cheng (2013)              136        56      8            75      40    6    1.29 (0.8--2.02)    
                   Timerbaeva (2015)         91         66      7            132     66    20   0.91 (0.62--1.32)   
                   Pooled data               1453       855     74           1255    597   91   0.97 (0.72--1.30)   Random
                   Heterogenity I^2^                                                            81.98%              
                   P~Q~                                                                         \<0.0001            
  **rs3842225**                                                                                                     
                   Clarimon (2005)           67         31      1            52      26    8    1.49 (0.84--2.66)   
                   Hague (2006)              168        80      7            144     71    8    1.07 (0.74--1.54)   
                   Kamm (2006)               326        174     21           156     82    5    0.91 (0.67--1.23)   
                   Clarimon (2007) U.S.      153        86      11           45      28    0    0.94 (0.57--1.57)   
                   Clarimon (2007) Italian   75         45      6            61      54    8    1.46 (0.91--2.33)   
                   Newman(2012)              116        65      6            125     61    12   1.00 0.68--1.48)    
                   Groen (2013)              231        119     11           226     122   15   1.09 (0.81--1.45)   
                   Timerbaeva (2015)         91         65      8            131     69    18   0.89 (0.62 1.31)    
                   Zhou (2015)               194        91      4            130     65    6    1.14 (0.78 1.65)    
                   Pooled data               1421       756     75           1070    578   80   1.05 (0.93--1.20)   Fixed
                   Heterogenity I^2^                                                            00.0%               
                   P~Q~                                                                         0.72                
  **rs13283584**                                                                                                    
                   Kamm (2006)               316        184     21           111     127   5    1.68 (1.26--2.24)   
                   Newman(2012)              119        69      7            124     67    16   1.11 (0.76--1.62)   
                   Pooled data               435        253     28           235     194   21   1.39 (0.93--2.08)   Random
                   Heterogenity I^2^                                                            65.72%              
                   P~Q~                                                                         0.09                
  **rs11787741**                                                                                                    
                   Kamm (2006)               323        177     21           156     82    5    0.89 (0.66--1.20)   
                   Newman(2012)              122        71      6            130     63    14   0.93 (0.68--1.46)   
                   Pooled data               445        248     27           286     145   19   1.00 (0.73--1.18)   Fixed
                   Heterogenity I^2^                                                            0.00%               
                   P~Q~                                                                         0.63                
  **rs13297609**                                                                                                    
                   Newman(2012)              137        57      6            134     61    10   1.17 (0.79--1.74)   
                   Cheng (2013)              134        62      4            79      37    5    1.11 (0.70--1.76)   
                   Pooled data               271        119     10           213     98    15   1.14 (0.85--1.54)   Fixed
                   Heterogenity I^2^                                                            0.00%               
                   P~Q~                                                                         0.86                

SNP, single nucleotide polymorphism; wt, homozygotes for wild allele; ht, heterozygotes; mt, homozygotes for mutant allele; CI, confidence interval; OR~G~, generalized odds ratio.

10.1371/journal.pone.0169934.t002

###### Quantitate measures of genetic risk (individual study estimates and pooled effects), stratified by polymorphism of interest, for focal dystonia group and its subtypes, with the generalized odds ratio (OR~G~).

![](pone.0169934.t002){#pone.0169934.t002g}

  Polymorphism/       Author (Year)             Controls   Cases   Model-free   Model                                      
  ------------------- ------------------------- ---------- ------- ------------ ------- ----- ---- ----------------------- -------
  **Focal**                                                                                                                
  **Dystonia**                                                                                                             
                      Bruggemann (2009)         184        53      4            209     77    9    1.33 (0.91--1.95)       
                      Chen (2012)               86         9       5            92      9     9    1.22 (0.59--2.53)       
                      Groen (2013)              267        84      9            262     91    11   1.12 (0.81--1.54)       
                      Wang (2016)               109        20      2            102     14    1    0.73 (0.36--1.47)       
                      Pooled data               646        166     20           665     191   30   1.15 (0.92--1.43)       Fixed
                      Heterogenity I^2^                                                            0.00%                   
                      P~Q~                                                                         0.52                    
  **Cervical**                                                                                                             
  **Dystonia**                                                                                                             
                      Bruggemann (2009)         184        53      4            73      35    3    1.66 (1.03--2.69)       
                      Chen (2012)               86         9       5            53      4     3    0.83 (0.32--2.12)       
                      Groen (2013)              267        84      9            262     91    11   1.12 (0.81--1.54)       
                      Wang (2016)               109        20      2            27      4     1    0.94 (0.33--2.66)       
                      Pooled data               466        166     20           425     134   18   1.21 (0.94--1.55)       Fixed
                      Heterogenity I^2^                                                            0.00%                   
                      P~Q~                                                                         0.52                    
  **Blepharospasm**                                                                                                        
                      Bruggemann (2009)         184        53      4            19      11    1    2.01 (0.94--4.27)       
                      Chen (2012)               86         9       5            15      1     2    1.28 (0.34--4.83)       
                      Wang (2016)               109        20      2            67      9     0    0.70 (0.31--1.58)       
                      Pooled data               379        82      11           101     21    3    1.24 (0.74--2.06)       Fixed
                      Heterogenity I^2^                                                            42.26%                  
                      P~Q~                                                                         0.17                    
  **Writer's**                                                                                                             
  **cramp**                                                                                                                
                      Bruggemann (2009)         184        53      4            25      13    3    2.10 (1.07--4.11)       
                      Chen (2012)               86         9       5            8       2     4    4.52 (1.48--13.82)      
                      Pooled data               270        62      9            33      15    7    **2.58 (1.45--4.58)**   Fixed
                      Heterogenity I^2^                                                            24.90%                  
                      P~Q~                                                                         0.24                    
  **rs1182**                                                                                                               
  **Focal**                                                                                                                
  **Dystonia**                                                                                                             
                      Clarimon (2007) U.S.      144        89      9            43      28    0    0.93 (0.55--1.56)       
                      Clarimon (2007) Italian   79         49      3            73      40    12   1.19 (0.75--1.91)       
                      Chen (2012)               205        86      3            98      48    2    1.18 (0.78--1.78)       
                      Groen (2013)              225        122     11           225     120   16   1.04 (0.78--1.39)       
                      Timerbaeva (2015)         91         66      7            103     54    18   0.98 (0.66 1.46)        
                      Pooled data               744        412     33           542     290   48   1.06 (0.89--1.26)       Fixed
                      Heterogenity I^2^                                                            0.00%                   
                      P~Q~                                                                         0.92                    
  **Cervical**                                                                                                             
  **Dystonia**                                                                                                             
                      Chen (2012)               205        86      3            58      22    1    0.92 (0.54--1.57)       
                      Groen (2013)              225        122     11           225     120   16   1.04 (0.78--1.39)       
                      Pooled data               430        208     14           283     142   17   1.01 (0.78--1.31)       Fixed
                      Heterogenity I^2^                                                            0.00%                   
                      P~Q~                                                                         0.69                    
  **Blepharospam**                                                                                                         
                      Clarimon (2007) U.S.      144        89      9            43      28    0    0.93 (0.55--1.56)       
                      Clarimon (2007) Italian   79         49      3            73      40    12   1.19 (0.75--1.91)       
                      Chen (2012)               205        86      3            13      9     0    1.68 (0.71--3.96)       
                      Pooled data               428        224     15           129     77    12   1.14 (0.83--1.57)       Fixed
                      Heterogenity I^2^                                                            0.00%                   
                      P~Q~                                                                         0.49                    
  **rs2296793**                                                                                                            
  **Focal**                                                                                                                
  **Dystonia**                                                                                                             
                      Clarimon (2007) U.S.      137        96      14           39      33    1    1.00 (0.61--1.63)       
                      Clarimon (2007) Italian   59         51      19           52      46    9    0.82 (0.52--1.29)       
                      Groen (2013)              211        131     15           213     129   19   1.02 (0.77--1.35)       
                      Zhou (2015)               194        90      5            132     61    8    1.10 (0.76--1.59)       
                      Wang (2016)               80         46      5            82      30    5    0.70 (0.42--1.16)       
                      Pooled data               681        414     58           518     299   42   0.96 (0.80--1.14)       Fixed
                      Heterogenity I^2^                                                            0.00%                   
                      P~Q~                                                                         0.61                    
  **Cervical**                                                                                                             
  **Dystonia**                                                                                                             
                      Groen (2013)              211        131     15           213     129   19   1.02 (0.77--1.35)       
                      Zhou (2015)               194        90      5            132     61    8    1.10 (0.76--1.59)       
                      Wang (2016)               80         46      5            21      11    0    0.84 (0.39--1.81)       
                      Pooled data               485        267     25           366     201   27   1.03 (0.83--1.28)       Fixed
                      Heterogenity I^2^                                                            0.00%                   
                      P~Q~                                                                         0.82                    
  **Blepharospam**                                                                                                         
                      Clarimon (2007) U.S.      137        96      14           39      33    1    1.00 (0.61--1.63)       
                      Clarimon (2007) Italian   59         51      19           52      46    9    0.82 (0.52--1.29)       
                      Wang (2016)               80         46      5            54      17    5    0.70 (0.39--1.25)       
                      Pooled data               276        193     38           145     96    15   0.85 (0.63--1.13)       Fixed
                      Heterogenity I^2^                                                            0.00%                   
                      P~Q~                                                                         0.65                    
  **rs3842225**                                                                                                            
  **Focal**                                                                                                                
  **Dystonia**                                                                                                             
                      Clarimon (2007) U.S.      153        86      11           45      28    0    0.94 (0.57--1.57)       
                      Clarimon (2007) Italian   75         45      6            61      54    8    1.46 (0.91--2.33)       
                      Groen (2013)              231        119     11           226     122   15   1.09 (0.81--1.45)       
                      Timerbaeva (2015)         91         65      8            102     57    16   0.97 (0.75--1.45)       
                      Zhou (2015)               194        91      4            130     65    6    1.14 (0.78--1.65)       
                      Pooled data               744        406     40           564     326   45   1.10 (0.93--1.31)       Fixed
                      Heterogenity I^2^                                                            0.00%                   
                      P~Q~                                                                         0.71                    
  **Cervical**                                                                                                             
  **Dystonia**                                                                                                             
                      Groen (2013)              231        119     11           226     122   15   1.09 (0.81--145)        Fixed
                      Zhou (2015)               194        91      4            130     65    6    1.14 (0.78--1.65)       
                      Pooled data               425        210     15           356     187   21   1.11 (0.88--1.39)       
                      Heterogenity I^2^                                                            0.00%                   
                      P~Q~                                                                         0.86                    

SNP, single nucleotide polymorphism; wt, homozygotes for wild allele; ht, heterozygotes; mt, homozygotes for mutant allele; CI, confidence interval; OR~G~, generalized odds ratio; Statistical significant OR~G~s of the pooled data are given in bold.

Discussion {#sec014}
==========

In the present meta-analysis, that included a relatively large number of participants, we investigated the effect of TOR1A gene SNPs on the risk of dystonia, as well as on the risk of focal dystonia and its subtypes (cervical dystonia, blepharospasm and writer's cramp). Our study detected a significant influence of a specific variant of TOR1A gene, rs1182, on the risk of focal dystonia. It also showed and that there is a strong association between rs1801968 and the development of task specific writer's cramp focal dystonia. To the best of our knowledge, this is the first meta-analysis examining the effect of TOR1A gene polymorphisms on the above-mentioned disorders.

Quite a few polymorphisms across TOR1A gene have been examined for possible association with dystonia, but the results from candidate gene association studies (CGASs) remain conflicting \[[@pone.0169934.ref020], [@pone.0169934.ref023]\]. Additionally, in the first meta-analysis and in a pooled analysis regarding TOR1A SNPs and dystonia no significant association was revealed \[[@pone.0169934.ref014], [@pone.0169934.ref023]\]. However, in a second meta-analysis a marginal statistical significance was revealed for rs1801968 only in a subgroup of patients with primary dystonia that also had a positive family history \[[@pone.0169934.ref024]\]. The lack of replication and the inconsistency of the results among CGASs, meta- and pooled- analyses about TOR1A gene and dystonia could be attributed to a number of reasons. Small sample sizes, low statistical power to detect associations and different ethnic backgrounds may have contributed to these discrepancies \[[@pone.0169934.ref024], [@pone.0169934.ref031]\]. Our study pooled patients from different ethnic groups. Specifically, rs1182 exhibited a significant effect in a cohort with focal dystonia (n = 880) consisting of a variety of nationalities (Caucasians, Africans, Americans, Hispanic, Italians, Chinese, Dutch and Slavs). Also, rs1801968 was found to be associated with writer's cramp in a cohort (n = 55) of German and Chinese patients. The large clinical phenotypic spectrum of dystonia and the fact that a dystonia patient can be assign in more than one phenotypic group \[[@pone.0169934.ref007], [@pone.0169934.ref014]\] could be an additional factor leading to conflicting results \[[@pone.0169934.ref014], [@pone.0169934.ref023]\]. In our study rs1801968 was found to be associated only with writer's cramp sub-phenotype and not with the entire focal dystonia phenotype. Moreover, the variability in the penetrance of mutations, the epistasis phenomenon and the interaction between genetic and environmental factors could be responsible for the discordance of the results \[[@pone.0169934.ref001], [@pone.0169934.ref024], [@pone.0169934.ref042]\].

The ΔGAG human variant of TorsinA was the first pathogenic, disease-causing mutation identified in early onset, generalized dystonia \[[@pone.0169934.ref043]\]. Thereafter, functional characterization of the growing number of the identified TOR1A variants in dystonia patients signifies the importance of the whole genetic variability across TOR1A gene \[[@pone.0169934.ref044]\]. Rs1801968 (D216H) is a functional missence coding polymorphism in exon 4 of TOR1A gene, which replaces the amino acid aspartic acid (D) with histidine (H) at residue 216 \[[@pone.0169934.ref045]\]. In a cell culture study, this amino acid substitution predisposes to the formation of inclusions similar to those formed by ΔGAG mutation \[[@pone.0169934.ref045]\]. However, the co-existence of 216H allele and ΔGAG mutation reduced the tendency for inclusions' formation \[[@pone.0169934.ref045]\]. This finding suggests that rs1801968 may have a protective role against the effect of ΔGAG mutation and dystonia \[[@pone.0169934.ref045]--[@pone.0169934.ref047]\]. On the contrary, 216D allele in cis together with ΔGAG, may predispose for developing dystonia \[[@pone.0169934.ref046], [@pone.0169934.ref047]\]. Cheng et al. reported that 216D allele was more abundant in patients with early-onset primary dystonia, while 216H allele was more frequent in the control group \[[@pone.0169934.ref041]\]. Furthermore, they observed that all the ΔGAG carriers, who also carried the 216D allele, were dystonic \[[@pone.0169934.ref041]\]. However, the great variance in the results from studies regarding the impact of rs18019168 on dystonia \[[@pone.0169934.ref023]\], suggests that additional factors influence the phenotypic manifestation of this polymorphism.

Rs1182, that also reached significance in our study, is located in the 3' untranslated region (3'-UTR) of exon 5 of TOR1A gene. However, there is no known functional effect of rs1182 on expression and function of TOR1A \[[@pone.0169934.ref048]\] so, the precise functional role of rs1182 on primary dystonia remains unclear. In addition to the effect of rs1182 on the risk of dystonia \[[@pone.0169934.ref036]--[@pone.0169934.ref038], [@pone.0169934.ref040]\], minor rs1182 allele may also represent a genetic factor influencing the spread of blepharospasm to adjacent body regions \[[@pone.0169934.ref049]\]. The role of another SNP, in particular rs3842225 polymorphism, that is also located in TOR1A 3'-UTR region of exon has also been examined in dystonia patients, but with ambiguous results \[[@pone.0169934.ref020]\]. There is only some indications that del allele of rs3842225 in cis with D216 allele of rs1801968 may be associated with reduced risk of dystonia \[[@pone.0169934.ref031], [@pone.0169934.ref047]\]. Furthermore, Clarimon et al. conducted a population-based study and described the association between dystonia and T2 haplotype which is consists of the minor alleles of rs1182, rs3842225 and rs2296793 \[[@pone.0169934.ref036]\]. No such association was revealed when each one of these three SNPs was examined separately \[[@pone.0169934.ref036]\]. Therefore, it is possible that SNPs within 3'-UTR of exon 5 represent an additional functional genetic locus of TOR1A, though it may be under synergic action with other TOR1A genetic variants.

Both variants emerged in our analysis may have some functional consequences. In particular, rs1182 is located in the UTR-3 that may affect transcription of TOR1A gene, whereas rs1801968 represents a missense mutation and is characterized as pathogenic in NCBI. In addition, an almost consistent effect across varied populations is also supportive of the significant role of both polymorphisms and by extension TOR1A gene. Moreover, the heterogeneity of effect size across studies it remained within acceptable limits (I^2^: 0--28%). However, it is not known whether these associations are causal without supportive functional analyses.

There are certain limitations in the present meta-analysis that must be acknowledged. \[[@pone.0169934.ref040]\]. Firstly, we included subjects regardless of the ΔGAG mutation status, the diagnostic methodology, the HWE values and the presence of positive family history or decent. We cannot also exclude a possible classification bias regarding the assignment of participants in dystonia phenotypes, as the majority of studies were performed before the dystonias' classification consensus update.

In conclusion, our meta-analysis revealed a possible influence of rs1182 TOR1A SNP on the risk of focal dystonia and of rs1801968 on the risk of writer's cramp. Further large-scale collaborative studies in different ethnic groups, with larger samples and with prospective and gene-environment interaction design are of great necessity in order to elucidate the role of TOR1A gene in focal dystonia. The investigation of additional genetic factors that predispose to dystonia may provide physicians with personalized tools for diagnosis, classification or treatment response.
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